Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bermudez (Marseille, France), N. Nathan (Paris, France), B. Coiffard (Marseille, France), A. Roux (Suresnes, France), S. Hirschi (Strasbourg, France), T. Degot (Strasbourg, France), V. Bunel (Paris, France), J. Le Pavec (Le Plessis Robinson, France), J. Macey (Bordeaux, France), A. Leborgne-Krams (Toulouse, France), V. Cottin (Lyon, France), R. Borie (Paris, France), M. Reynaud-Gaubert (Marseille, France). Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism. 2918

Member's Comments

No comment yet.

Related content which might interest you: Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Late Breaking Abstract: Comparison between referral diagnosis of patients requiring transplantation due to interstitial lung diseases and pathological diagnosis of native lungs Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract: Tiotropium improves lung function in patients with severe uncontrolled asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Poor patient adherence may contribute to increased skin cancer risk in heart and lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015 Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 Factors affecting lung function in adult cystic fibrosis patients after lung transplantation. Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Structural lung disease in adult survivors of bronchopulmonary dysplasia Source: Annual Congress 2013 –Neonatal and paediatric intensive care Year: 2013 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015